Liver Transplantation in HIV-Seropositive Individuals
- Margaret V. Ragni, MD, MPH;
- Steven H. Belle, PhD;
- KyungAh Im, BS;
- John Fung, MD, PhD;
- Guy Neff, MD;
- Michelle Roland, MD;
- Peter Stock, MD;
- Nigel Heaton, MD; and
- Abhi Humar, MD
- From the University of Pittsburgh, Pittsburgh, PA 15260; Cleveland Clinic Foundation, Cleveland, OH 44195; The University Hospital, Cincinnati, OH 45219; University of California, San Francisco, San Francisco, CA 94143; King's College, London WC2R 2LS, United Kingdom; and University of Minnesota Medical Center, Minneapolis, MN 55454.
TO THE EDITOR:
We were pleased that our recent paper (1) concerning liver transplantation in HIV-infected individuals was chosen for the 2005 Update in Gastroenterology and Hepatology (2), but we would like to clarify a few points about our paper and this evolving field.
Contrary to the review by Drs. Koretz and Lipman, this was a prospective study of consecutively enrolled HIV-seropositive liver transplant recipients who underwent the procedure according to the same listing criteria as HIV-seronegative recipients. We felt compelled to carry out this study because 1) significant advances had occurred in the area of highly active antiretroviral therapy …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
